Honesty and accountability is everything to us. We cherish the trust we have in each other as a team and the confidence our partners have in us.
Our team is full of people who are committed to open communication—listening well and asking good questions. This fosters an atmosphere of personal growth and betterment that leads to a stronger team as a whole.
Often, in science, challenges arise that have no clear solution. We look for creative solutions to difficult challenges, and we have the courage to implement those changes.
Abveris is dedicated to providing high quality, effective services with the urgency required to meet critical project timelines.
Tracey Mullen is a chemical-biological engineer from MIT who began her career as an Antibody Discovery Scientist at a startup contract research organization specializing in in vivo antibody discovery. Before bringing her talent to Abveris, she helped implement the technology transfer of the Adimab yeast display platform for antibody discovery and engineering at Biogen. Throughout her tenure at Biogen, Tracey worked to optimize the in vitro discovery of antibodies to tough targets, including leveraging the Adimab platform to generate antibodies against GPCRs.
Colby provides scientific leadership for the team to guide decisions and develop innovative strategies for successful delivery of each unique project. Before Abveris, he graduated with a Ph. D. in Cell and Molecular Biology from Texas A&M and directed antibody discovery and engineering programs at both MassBiologics of the University of Massachusetts Medical School and Kanyos Bio.
Ryan is a graduate of the Harvard Dept. of Molecular and Cellular Biology and the Business Development Team Lead for In Vivo Antibody Discovery Services at Twist Bioscience. Ryan works with diverse pharmaceutical partners to develop scientifically and commercially reasonable antibody discovery strategies underlying the next generation of biologics and in vitro diagnostics.
(LEADERSHIP TEAM)
